Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of Apo A-I and HDL-cholesterol

This publication has 21 references indexed in Scilit:

• Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
  Atherosclerosis, 1995
• In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
• Role of genetic variation at the Apo AI‐CIII‐AIV gene cluster in determining plasma Apo AI levels in boys and girls
  Genetic Epidemiology, 1993
• Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations
  Human Genetics, 1992
• Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: The Bogalusa heart study
  Genetic Epidemiology, 1987
• The inheritance of high density lipoprotein cholesterol and apolipoproteins A-I and A-II
  Atherosclerosis, 1984
• Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
  New England Journal of Medicine, 1982
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977
• THE TROMSØHEART-STUDY
  The Lancet, 1977